![]() |
||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||||||||
| Products | ||||||||||||||||||||||||||||||||
Comprehensive Cardiovascular Assessment Heart disease and stroke (the principal components of cardiovascular disease) are the first and third leading causes of death in the United States and account for more then 40% of all deaths. Coronary heart disease is a leading cause of premature permanent disability among working adults. GeneLink’s Comprehensive Cardio Assessment incorporates twenty-six SNPs (within twenty-one genes) associated with a variety of important cardio-functional areas that modulate blood pressure regulation, lipid balance and metabolism, vascular integrity, procoagulation, platelets and oxidative stress. GeneLink’s Comprehensive Cardio Assessment is an important assessment tool for determining individual susceptibilities and for creating therapies that help minimize cardiovascular related events and conditions. |
||||||||||||||||||||||||||||||||
|
|
© Copyright 2008, GeneLink BioSciences, Inc. All Rights Reserved. GeneLink is a Registered Trademark of © GeneLink BioSciences, Inc. |
||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||